% | $
Quotes you view appear here for quick access.

Petróleo Brasileiro S.A. - Petrobras Message Board

sandyeggojake 11 posts  |  Last Activity: Oct 22, 2014 12:23 PM Member since: Mar 2, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Ominous technicals with CMG post earnings...

    by sandyeggojake Oct 20, 2014 4:24 PM
    sandyeggojake sandyeggojake Oct 22, 2014 12:23 PM Flag

    As called, the gap filled. But now just a narrow band of support around $600 level till rising MA(200)d at about $589.93. With this warning, there will be much sell pressure overhead, so longs will be cautious on this bounce.

    Sentiment: Strong Sell

  • If one looks at a broader daily chart w/ today including afterhours, we see a snap back bear rally to the MA(50)d, that was then crushed back to a new period low with volume. Looking like a sure inverted hammer.

    Things get very mushy until a $600 level gap fill.

    Sentiment: Strong Sell

  • With a close today above $4.85 (the 9/16 open), $OREX will paint a bullish outside reversal day. Volume still low, but day is still young. A close above $5 should set up a retest of the MA(50)d. (We added a T3 on the break above $4.80.)

  • Reply to

    What makes contrave different than Q or B?

    by matese16 Sep 11, 2014 12:02 PM
    sandyeggojake sandyeggojake Sep 11, 2014 12:15 PM Flag

    Like you I was invested in arna, and avoided vvus. But have long been impressed by the robust safety and efficacy package that orex has put together. I think after phenfen, safety has been an issue keeping some pts and docs on the sideline. But orex has a robust safety package - in my eyes, better than the two former.

    Also, from a marketing prospective, this opportunity is primed to surprise. Takeda is by far a better PCP / endo sector marketing partner, and they will drive NRx trial. And already there are legions of prospective pts those who have tried and failed arna and/or vvus, and are willing to try something new. And then there is Europe, which I think will be a real point of differentiation in terms of sale potential.

    We shall see, but this sell the news action was expected. We even wrote about it here a few days back. Hopefully there are those that did as we have and kept some dry powder.

  • sandyeggojake sandyeggojake Sep 11, 2014 11:31 AM Flag

    Price action seems to be a combination of shorts (who trimmed & hedged in the run up) are now refilling short positions, given their expectations of similar slow sales uptake, combined with stop loss triggering and technical selling on failure to make new high swing high / breakout of primary resistance.

    But I expect obesity Rx market is much better primed for a new agent. Lot of V & B failures who are ready for something new to try. And Takeda is a world class marketer.

    Since 11/2013, $OREX is in a pinching triangle, and has yet to break it's rising support trend. Expecting shorts to push technicals why potential longs lick chops and wait to digest news.

  • Reply to

    Technicals getting ugly in $AAPL

    by sandyeggojake Sep 9, 2014 3:21 PM
    sandyeggojake sandyeggojake Sep 9, 2014 4:08 PM Flag

    Well, a close below $98 level and prior day close is not the worst. Holding above MA(50)d and prior swing high was absolutely required. But the week is young, and technical theory suggests these marks will be retested. And since both cut on first attempt, they are seriously weak.

  • $AAPL has been a savior for the entire market this summer, allow it to push to new highs. But the new phone is out and sell the news is here... Bearish technicals are everywhere...

    Failure to set a new swing high.
    Failure to hold $100 mark.
    Failure to hold prior day close
    Failure to hold prior week close
    Failure to hold prior month close
    Failure to hold MA(50)d $96.91 (cut on first attempt)
    Failure to hold prior swing high of $96.21 (cut on first attempt)

    Day is not over, but expect many trailing stop losses to be triggered, which will create both further overhead resistance as well as risk of waterfall impact below. And potential for negative feedback between broader markets and aapl .

    Over last wk, we now sold 1/3 of our position, and a second 1/3 today, all of which was purchased between Dec '12 and October '13. Will pull the ripcord on last 1/3 on first close below $96.21.

  • Reply to

    Technical read $OREX 9/8

    by sandyeggojake Sep 8, 2014 3:20 PM
    sandyeggojake sandyeggojake Sep 9, 2014 3:06 PM Flag

    This 9/9 move to the 5.85 support range is little more than a technical reaction given stop losses to the AM breaks to the MA(50)d and the $6 level. Bulls will note the $5.81 support held (Fridays low). Technically, while some damage has been done, it is still early in the day and a snap back rally would be a very strong bullish technical sign. But even if that does happen, it doesn't get technically ugly unless she closes below the MA(50)d now at $5.55.

  • Reply to

    Approval with Warning?w

    by pretzel223 Sep 9, 2014 2:13 PM
    sandyeggojake sandyeggojake Sep 9, 2014 2:54 PM Flag

    Obviously it gets a warning... already stated such is expected. Which is unlike KERX or MNKD, where the warnings were not expected. As such, any warnings will be a nonevent ...though expect shorts to try to make it into one.

  • Reply to

    Technical read $OREX 9/8

    by sandyeggojake Sep 8, 2014 3:20 PM
    sandyeggojake sandyeggojake Sep 8, 2014 3:40 PM Flag


    Fair comment. But to be clear, I am not advocating any sell the news part as this strategy has been broadly hyped. I suspect that there are many funds that have held off building any position in $OREX given the price action and sales results of $OREX competitors, expecting they can do so post PDUFA.

    Of course, neither competitor have Takeda as a marketing partner, so I expect it to be relatively easy for them to beat the beaten down launch expectations.

  • sandyeggojake by sandyeggojake Sep 8, 2014 3:20 PM Flag

    General read is obviously bullish, with today testing and making a new swing high ($6.14) on its first attempt, plus the rising probability of first close over its once again rising MA(200)d since early july. After the new swing high, the price action rested with a pull back to the prior resistance level ($6), now classically acting as support. With PDUFA date looming, expecting increased volume.

    Still, many are suggesting this will be a sell the news candidate after a positive pop. However, consider if the stock price hold in this $6 support range post event, the MA(50)d will soon start to climb and upcross the MA(200)d (golden cross). And if the move should cross the $8 level (a new buy signal on the old school P&F chart) market mechanics might quickly lead an extended rally, given short interest is already about 10 day to cover.

5.86+0.08(+1.38%)Aug 31 4:02 PMEDT